Recruiting Xeroderma Pigmentosum Studies in Hackensack
About Xeroderma Pigmentosum Clinical Trials in Hackensack
Xeroderma pigmentosum is a rare genetic disorder characterized by extreme sensitivity to ultraviolet light, leading to very high risk of skin cancer and eye damage. It is caused by defects in DNA repair mechanisms. Management requires strict UV protection and vigilant cancer surveillance.
There are currently 2 xeroderma pigmentosum clinical trials recruiting participants in Hackensack, NJ. These studies are seeking a combined 97 participants. Research is being sponsored by Context Therapeutics Inc., Vironexis Biotherapeutics Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Xeroderma Pigmentosum Clinical Trials in Hackensack — FAQ
Are there xeroderma pigmentosum clinical trials in Hackensack?
Yes, there are 2 xeroderma pigmentosum clinical trials currently recruiting in Hackensack, NJ. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Hackensack?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hackensack research site will contact you about next steps.
Are clinical trials in Hackensack free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hackensack studies also compensate for your time and travel.
What xeroderma pigmentosum treatments are being tested?
The 2 active trials in Hackensack are testing new therapies including novel drugs, biologics, and treatment approaches for xeroderma pigmentosum.
Data updated July 13, 2026 from ClinicalTrials.gov